Paul Manu, C S Guruprasad, Kumar Aswin, Boddu Deepthi, R Prasanth V, Nair Manjusha, R Binitha, K Jayasree, George Preethi Sara, Augustine Paul, Sugath Bhaskar Subin, T Priyakumari
Department of Surgical Services, Regional Cancer Centre, Thiruvananthapuram, Kerala India.
Department of Paediatric Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala India.
Indian J Surg Oncol. 2025 Feb;16(1):31-37. doi: 10.1007/s13193-024-02019-4. Epub 2024 Jul 11.
Reconstruction of a paediatric bone tumour after wide excision is challenging. Autologous sterilized tumour bone provides a perfect fit, avoids wear and tear of the prosthesis, and promises longevity of reconstruction. Here we present our experience on wide excision and reconstruction with irradiated tumour bone at our institution which is a high-volume paediatric sarcoma care centre. This is a retrospective analysis of 53 paediatric patients who underwent reconstruction with irradiated tumour bone between 01/01/2011 and 31/12/2021. The median follow-up period was 64 months (6-112 months) and 83.3% of patients had a minimum follow-up of 3 years. There were 44 diaphyseal osteotomies and 42 metaphyseal osteotomies. Short-term complications were seen in ten patients (18.9%). The long-term complications were high, but 65% of cases were successfully managed and at the time of analysis, only 15 patients had morbidity related to long-term complications. A total of seven patients (13.2%) had persistent nonunion even after additional procedures like bone grafting and refixation. There were four isolated local recurrences in our series (7.5%), and all of these occurred in the soft tissue. The 5-year overall survival was 75.7%, and 5-year disease-free survival was 63%. Reconstruction with irradiated tumour bone is an oncologically safe procedure with acceptable morbidity. Although it is not a procedure without complications, it is an excellent option for reconstruction in paediatric bone tumours.
广泛切除术后小儿骨肿瘤的重建具有挑战性。自体无菌肿瘤骨贴合度极佳,可避免假体磨损,并有望实现长期的重建效果。在此,我们介绍在我们机构(一家大型小儿肉瘤治疗中心)使用经照射的肿瘤骨进行广泛切除和重建的经验。这是一项对2011年1月1日至2021年12月31日期间接受经照射肿瘤骨重建的53例小儿患者的回顾性分析。中位随访期为64个月(6 - 112个月),83.3%的患者至少随访了3年。有44例骨干截骨术和42例干骺端截骨术。10例患者(18.9%)出现短期并发症。长期并发症发生率较高,但65%的病例得到了成功处理,在分析时,只有15例患者存在与长期并发症相关的发病情况。即使在进行了诸如植骨和重新固定等额外手术后,仍有7例患者(13.2%)持续骨不连。我们的系列中有4例孤立的局部复发(7.5%),所有这些均发生在软组织中。5年总生存率为75.7%,5年无病生存率为63%。用经照射的肿瘤骨进行重建是一种肿瘤学上安全的手术,发病率可接受。尽管这不是一种没有并发症的手术,但它是小儿骨肿瘤重建的一个极佳选择。